All News

Sandra Christensen, MSN, ARNP, gives her top strategies on patient selection for treatment with antiobesity medications and how to choose the right drugs for patients.

Your daily dose of the clinical news you may have missed.

Less than one-quarter of US adults surveyed said they would "definitely" get the shot while 33% stated they would "definitely not" get the new vaccine.

Amy Houtrow, MD, PhD, MPH, considers the impact of poverty on childhood disability and talks about opportunities to breach barriers to health care access.

An e-health lifestyle walking intervention partially supported by remote coaching led to significant improvement in BP in older adults as well as a desire to keep walking.

Etripamil 70 mg nasal spray restored heart rate within 30 minutes in approximately 60% of PSVT episodes, report authors of new study.

The 2022 AAFP Clinical Practice Guideline on hypertension treatment in adults is the subject matter for this 10-question topline quiz that is also a good source of review.

Your daily dose of the clinical news you may have missed.

Among postmenopausal women taking hormones orally, the NAFLD prevalence increased from 25.3 to 29.4% while it decreased from 24 to 17.3% in those using the transdermal route.

The US Food and Drug Administration granted BTD to pegozafermin for the treatment of patients with NASH.

Your daily dose of the clinical news you may have missed.

Pivotal cardiovascular outcome trials that evaluated cardiorenal benefits of the newer classes were not designed to consider racial/ethnic variations, researchers state.

How can a nearby physiatrist help your patient with hypertension? If comorbid arthritis has the person couchbound, a consult and some PT could go a long way.

Members of the ACIP voted on Friday to recommend Pfizer’s maternal bivalent RSVpreF vaccine to protect newborns from severe RSV illness.

Your daily dose of the clinical news you may have missed.

The biosimilar to the GLP-1 mimetic Victoza proved noninferior for reduction of HbA1c and had similar positive effects on body weight, lipids, and blood pressure.

The patient with neck pain might be better off referred to a physiatrist for additional evaluation and possibly treatment, according to PM&R physician Atul Patel, MD.

Empagliflozin is approved to lower the risk of sustained decline in eGFR, end-stage kidney disease, CV death, and hospitalization in adults with CKD at risk of progression.